Educational Programs for Cancer Survivors and Their Partners
(PEPP Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to explore how well two educational programs can improve sexual communication between women who have had breast or gynecological cancer and their partners. The study will test two different versions of a workbook that participants will complete independently, with regular check-ins. Women who completed their primary cancer treatment in the last 3 to 10 years and have noticed changes in their relationship communication are ideal candidates. As an unphased trial, this study offers a unique opportunity to contribute to research that may enhance relationship communication for many others in similar situations.
Will I have to stop taking my current medications?
The trial does not require you to stop taking your current medications. You can continue maintenance therapy, adjuvant endocrine therapy, and certain psychiatric medications if you've been on them for at least 30 days before joining the study.
What prior data suggests that these educational programs are safe?
Studies have shown that programs like PEPP, including the Cancer Patient Empowerment Program (PC-PEP), are generally safe for participants. People who have completed cancer treatment find these programs manageable. Research indicates that these programs can reduce stress and enhance overall well-being without causing harm.
Participants in these programs did not report any major negative side effects. Many experienced emotional improvement and better relationships. This suggests that the PEPP program should also be safe for participants. However, discussing any concerns with a healthcare professional before joining a trial is important.12345Why are researchers excited about this trial?
Researchers are excited about the PEPP educational programs for cancer survivors and their partners because they offer a fresh approach to support and education. Unlike traditional in-person support groups or counseling sessions, PEPP leverages a self-guided workbook that participants can navigate at their own pace in the comfort of their home. This method not only provides flexibility but also ensures continuous engagement through regular check-ins via email or text, which is a unique feature compared to standard options. By empowering participants to independently work through the program with periodic guidance, PEPP aims to enhance adherence and address personal concerns effectively.
What evidence suggests that this trial's educational programs could be effective for cancer survivors and their partners?
Research shows that educational programs like PEPP (Psychosexual Educational Partners Program) can benefit cancer survivors. This trial will evaluate two versions of the PEPP program: the Self-Guided PEPP Intervention Workbook and the Self-Guided PEPP Education Workbook. Studies on similar programs have found that they greatly reduce stress and improve emotional health for cancer patients. These programs also help maintain strong relationships, which is important for both patients and their partners. Although specific data on PEPP's effectiveness is still being collected, early results from similar programs are encouraging. They suggest that these educational programs could enhance communication between partners, including about sexual matters.14567
Who Is on the Research Team?
Noel M Arring, DNP, PhD, RN
Principal Investigator
University of Tennessee Knoxville
Are You a Good Fit for This Trial?
This trial is for women who have finished treatment for breast or gynecological cancer and their partners. It aims to help with sexual communication post-treatment. The study will include 30 pairs (dyads) of patients and partners, but specific inclusion and exclusion criteria details are not provided.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants engage in a self-paced, workbook-based intervention over six weeks
Follow-up
Participants are monitored for adherence, acceptance, and adverse events after treatment
What Are the Treatments Tested in This Trial?
Interventions
- PEPP
Find a Clinic Near You
Who Is Running the Clinical Trial?
The University of Tennessee, Knoxville
Lead Sponsor
Breast Cancer Research Foundation
Collaborator